Evidence map›Paper›PMID 29333091›Full record

ArticleInternational journal of medical sciences2018

Qianwen Shao, Jing Xu, Xin Guan, Bing Zhou, Wei Wei, Rong Deng, Dongzhen Li, Xinyu Xu, Haitao Zhu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. [Advancement of E2F1 in Common Tumors].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2020
    Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Qianwen ShaoDepartment of Oncology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Guangzhou Road 300, Nanjing 210029, Jiangsu Province, China.
Jing XuDepartment of Oncology, The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Guangzhou Road 300, Nanjing 210029, Jiangsu Province, China.
Xin GuanDepartment of General Surgery, Cancer Hospital of Nanjing Medical University, Baiziting 42, Nanjing 210009, Jiangsu Province, China.
Bing ZhouDepartment of General Surgery, Cancer Hospital of Nanjing Medical University, Baiziting 42, Nanjing 210009, Jiangsu Province, China.
Wei WeiDepartment of General Surgery, Cancer Hospital of Nanjing Medical University, Baiziting 42, Nanjing 210009, Jiangsu Province, China.
Rong DengDepartment of General Surgery, Cancer Hospital of Nanjing Medical University, Baiziting 42, Nanjing 210009, Jiangsu Province, China.
Dongzhen LiDepartment of General Surgery, Cancer Hospital of Nanjing Medical University, Baiziting 42, Nanjing 210009, Jiangsu Province, China.
Xinyu XuDepartment of Pathology, Cancer Hospital of Nanjing Medical University, Baiziting 42, Nanjing 210009, Jiangsu Province, China.
Haitao ZhuDepartment of General Surgery, Cancer Hospital of Nanjing Medical University, Baiziting 42, Nanjing 210009, Jiangsu Province, China.
Nanjing Medical University · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to analyze the

Indexed as

Gene Expression Regulation, NeoplasticAnimalsAntineoplastic Agentsbeta CateninCell Line, TumorCell ProliferationCell Self RenewalDrug Resistance, NeoplasmE2F1 Transcription FactorFemaleGene DeletionGenetic VectorsHumansLentivirusMaleMiceAntineoplastic Agentsbeta CateninCTNNB1 protein, humanE2F1 protein, humanE2F1 Transcription FactorHIPK1 protein, humanMicroRNAsMIR17HG, humanProtein Serine-Threonine KinasesRNA, Long Noncodinggastric cancermiRNA-19b/20a/92amolecular mechanism.

Identifiers

PMID29333091
PMCPMC5765743
OpenAlexW2775195374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.